Comment on: Equal rights in autoimmunity: Is Sjögren's syndrome ever 'secondary'?: Reply

Florian Kollert; Benjamin A. Fisher

doi:10.1093/rheumatology/keaa631

Comment on: Equal rights in autoimmunity: Is Sjögren's syndrome ever 'secondary'?: Reply

Florian Kollert, Benjamin A. Fisher^*

^*Corresponding author for this work

Inflammation and Ageing

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	E34-E34
Number of pages	1
Journal	Rheumatology (United Kingdom)
Volume	60
Issue number	1
Early online date	19 Nov 2020
DOIs	https://doi.org/10.1093/rheumatology/keaa631
Publication status	Published - Jan 2021

Bibliographical note

Funding:
B.A.F. has received support from the NIHR Birmingham Biomedical Research Centre. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health.

ASJC Scopus subject areas

Rheumatology
Pharmacology (medical)

Access to Document

10.1093/rheumatology/keaa631Licence: None: All rights reserved

Cite this

@article{0222c09e576a4d43b7aa37def1959049,

title = "Comment on: Equal rights in autoimmunity: Is Sj{\"o}gren's syndrome ever 'secondary'?: Reply",

author = "Florian Kollert and Fisher, {Benjamin A.}",

note = "Funding: B.A.F. has received support from the NIHR Birmingham Biomedical Research Centre. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health.",

year = "2021",

month = jan,

doi = "10.1093/rheumatology/keaa631",

language = "English",

volume = "60",

pages = "E34--E34",

journal = "Rheumatology (United Kingdom)",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "1",

}

TY - JOUR

T1 - Comment on

T2 - Equal rights in autoimmunity: Is Sjögren's syndrome ever 'secondary'?: Reply

AU - Kollert, Florian

AU - Fisher, Benjamin A.

N1 - Funding: B.A.F. has received support from the NIHR Birmingham Biomedical Research Centre. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health.

PY - 2021/1

Y1 - 2021/1

UR - http://www.scopus.com/inward/record.url?scp=85099427584&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/keaa631

DO - 10.1093/rheumatology/keaa631

M3 - Comment/debate

C2 - 33212500

AN - SCOPUS:85099427584

SN - 1462-0324

VL - 60

SP - E34-E34

JO - Rheumatology (United Kingdom)

JF - Rheumatology (United Kingdom)

IS - 1

ER -